ID

12005

Beschrijving

Efficacy and Safety of Olmesartan Associated With Chlorthalidone in Essential Arterial Hypertension Control; ODM derived from: https://clinicaltrials.gov/show/NCT02493322

Link

https://clinicaltrials.gov/show/NCT02493322

Trefwoorden

  1. 31-08-15 31-08-15 -
Houder van rechten

ODM derived from: https://clinicaltrials.gov/show/NCT02493322

Geüploaded op

31 augustus 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Essential Arterial Hypertension NCT02493322

Eligibility Essential Arterial Hypertension NCT02493322

Inclusion Criteria
Beschrijving

Inclusion Criteria

signed consent of the patient;
Beschrijving

consent

Datatype

boolean

Alias
UMLS CUI [1]
C0514044
participants with decompensated essential hypertension, classified into stage 1 (with high or very high cardiovascular risk), stage 2 or stage 3 according to the brazilian society of cardiology (2010), who have never been treated and have indication for drug combination treatment.
Beschrijving

cardiovascular; participants; hypertension; on treatment; combination; indication; stage; never; high; drug; very

Datatype

boolean

Alias
UMLS CUI [1]
C0085580
obs: the diagnosis may be established by previous evaluation of two blood pressure measures ≥ 140/90 mmhg, with two months difference between measurements
Beschrijving

blood pressure; diagnosis

Datatype

boolean

Alias
UMLS CUI [1]
C0857121
Exclusion Criteria
Beschrijving

Exclusion Criteria

patients with any clinically significant disease that in the investigator is opinion can not participate in the study;
Beschrijving

clinically significant; investigator; disease; study

Datatype

boolean

Alias
UMLS CUI [1]
C0012634
secondary hypertension diagnosis or blood pressure above 190x100 mmhg in the screening/randomization visit;
Beschrijving

blood pressure; randomization; hypertension; diagnosis; screening; visit

Datatype

boolean

Alias
UMLS CUI [1]
C0155616
morbid obesity or immunocompromised patients;
Beschrijving

immunocompromised; obesity

Datatype

boolean

Alias
UMLS CUI [1]
C0085393
UMLS CUI [2]
C0028754
participants with greater than 10 mmhg difference in the measurements of systolic or diastolic blood pressure between the two arms;
Beschrijving

diastolic blood pressure; participants; systolic; arms

Datatype

boolean

Alias
UMLS CUI [1]
C3160850
participants who do not have the two upper limbs;
Beschrijving

participants; upper

Datatype

boolean

Alias
UMLS CUI [1]
C1140618
participants with important electrocardiographic changes;
Beschrijving

participants

Datatype

boolean

Alias
UMLS CUI [1]
C0855329
creatinine clearance - less than 60 ml /min;
Beschrijving

creatinine clearance

Datatype

boolean

Alias
UMLS CUI [1]
C0373595
history of hypertensive emergencies and cardiovascular and / or moderate to severe cerebrovascular events in the past 6 months;
Beschrijving

cardiovascular; moderate; severe; events

Datatype

boolean

Alias
UMLS CUI [1]
C1561291
microalbuminuria in urine sample greater than 30 mg/g;
Beschrijving

microalbuminuria; urine

Datatype

boolean

Alias
UMLS CUI [1]
C0730345
patients with history of hypersensitivity to any of the formula compounds;
Beschrijving

history of hypersensitivity to mistletoe

Datatype

boolean

Alias
UMLS CUI [1]
C0020517
pregnancy or risk of pregnancy and lactating patients;
Beschrijving

pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C2828358
UMLS CUI [2]
C0549206
participation in clinical trial in the year prior to this study.
Beschrijving

clinical trial; study; year

Datatype

boolean

Alias
UMLS CUI [1]
C0008976

Similar models

Eligibility Essential Arterial Hypertension NCT02493322

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
consent
Item
signed consent of the patient;
boolean
C0514044 (UMLS CUI [1])
cardiovascular; participants; hypertension; on treatment; combination; indication; stage; never; high; drug; very
Item
participants with decompensated essential hypertension, classified into stage 1 (with high or very high cardiovascular risk), stage 2 or stage 3 according to the brazilian society of cardiology (2010), who have never been treated and have indication for drug combination treatment.
boolean
C0085580 (UMLS CUI [1])
blood pressure; diagnosis
Item
obs: the diagnosis may be established by previous evaluation of two blood pressure measures ≥ 140/90 mmhg, with two months difference between measurements
boolean
C0857121 (UMLS CUI [1])
clinically significant; investigator; disease; study
Item
patients with any clinically significant disease that in the investigator is opinion can not participate in the study;
boolean
C0012634 (UMLS CUI [1])
blood pressure; randomization; hypertension; diagnosis; screening; visit
Item
secondary hypertension diagnosis or blood pressure above 190x100 mmhg in the screening/randomization visit;
boolean
C0155616 (UMLS CUI [1])
immunocompromised; obesity
Item
morbid obesity or immunocompromised patients;
boolean
C0085393 (UMLS CUI [1])
C0028754 (UMLS CUI [2])
diastolic blood pressure; participants; systolic; arms
Item
participants with greater than 10 mmhg difference in the measurements of systolic or diastolic blood pressure between the two arms;
boolean
C3160850 (UMLS CUI [1])
participants; upper
Item
participants who do not have the two upper limbs;
boolean
C1140618 (UMLS CUI [1])
participants
Item
participants with important electrocardiographic changes;
boolean
C0855329 (UMLS CUI [1])
creatinine clearance
Item
creatinine clearance - less than 60 ml /min;
boolean
C0373595 (UMLS CUI [1])
cardiovascular; moderate; severe; events
Item
history of hypertensive emergencies and cardiovascular and / or moderate to severe cerebrovascular events in the past 6 months;
boolean
C1561291 (UMLS CUI [1])
microalbuminuria; urine
Item
microalbuminuria in urine sample greater than 30 mg/g;
boolean
C0730345 (UMLS CUI [1])
history of hypersensitivity to mistletoe
Item
patients with history of hypersensitivity to any of the formula compounds;
boolean
C0020517 (UMLS CUI [1])
pregnancy
Item
pregnancy or risk of pregnancy and lactating patients;
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
clinical trial; study; year
Item
participation in clinical trial in the year prior to this study.
boolean
C0008976 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial